CLNN Clene Inc.

Nasdaq Pharmaceutical Preparations DE CIK: 0001822791
AI RATING
STRONG_SELL
95% Confidence

Investment Thesis

Clene Inc. exhibits severe financial distress with negative stockholders' equity of -$18.8M, indicating technical balance sheet insolvency. The company generates negligible revenue ($15.0K) while burning approximately $4.5M annually in operating cash flows, providing less than 1.5 years of runway on current cash reserves. Despite modest YoY loss improvement, the fundamental absence of commercial revenue and heavy leverage relative to assets presents extreme risk.

Strengths

  • + Cash position of $5.9M provides near-term liquidity buffer
  • + Net loss improved 33.6% YoY suggesting cost discipline efforts
  • + Current and Quick ratios above 1.9x indicate acceptable short-term solvency

Risks

  • ! Negative stockholders' equity of -$18.8M represents technical insolvency and complete equity value destruction
  • ! Operating cash burn of -$4.5M annually with only 1.3 years of cash runway remaining
  • ! Total liabilities ($40.5M) nearly double total assets ($21.7M) creating severe leverage pressure
  • ! Revenue collapse of -41.5% YoY with near-zero revenue generation capability

Key Metrics to Watch

Financial Metrics

Revenue
15.0K
Net Income
-8.1M
EPS (Diluted)
$-0.46
Free Cash Flow
-4.6M
Total Assets
21.7M
Cash
5.9M

Profitability Ratios

Gross Margin N/A
Operating Margin -13,740.0%
Net Margin -53,940.0%
ROE N/A
ROA -37.3%
FCF Margin -30,446.7%

Balance Sheet & Liquidity

Current Ratio
1.94x
Quick Ratio
1.93x
Debt/Equity
N/A
Debt/Assets
186.8%
Interest Coverage
-2.61x
Long-term Debt
17.7M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-15T07:02:12.965193 | Data as of: 2026-03-31 | Powered by Claude AI